189 related articles for article (PubMed ID: 25064473)
1. HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 human papillomavirus genotype microarray system.
Bonde J; Rebolj M; Ejegod DM; Preisler S; Lynge E; Rygaard C
BMC Infect Dis; 2014 Jul; 14():413. PubMed ID: 25064473
[TBL] [Abstract][Full Text] [Related]
2. Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study.
Ejegod DM; Rebolj M; Bonde J
BMC Cancer; 2015 Apr; 15():216. PubMed ID: 25886410
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study.
Preisler S; Rebolj M; Ejegod DM; Lynge E; Rygaard C; Bonde J
BMC Cancer; 2016 Jul; 16():510. PubMed ID: 27439470
[TBL] [Abstract][Full Text] [Related]
4. Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland.
Leinonen MK; Anttila A; Malila N; Dillner J; Forslund O; Nieminen P
Br J Cancer; 2013 Nov; 109(11):2941-50. PubMed ID: 24136148
[TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above.
Rebolj M; Bonde J; Preisler S; Ejegod D; Rygaard C; Lynge E
PLoS One; 2016; 11(1):e0147326. PubMed ID: 26789267
[TBL] [Abstract][Full Text] [Related]
6. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
7. Clinical performance of the CLART human papillomavirus 2 assay compared with the hybrid capture 2 test.
Pista A; Verdasca N; Oliveira A
J Med Virol; 2011 Feb; 83(2):272-6. PubMed ID: 21181922
[TBL] [Abstract][Full Text] [Related]
8. Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening.
Ejegod DM; Lagheden C; Bhatia R; Pedersen H; Boada EA; Sundström K; Cortés J; Josë FXB; Cuschieri K; Dillner J; Bonde J
BMC Cancer; 2020 May; 20(1):396. PubMed ID: 32375689
[TBL] [Abstract][Full Text] [Related]
9. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015.
Balanda M; Quiero A; Vergara N; Espinoza G; Martín HS; Rojas G; Ramírez E
Med Microbiol Immunol; 2016 Dec; 205(6):585-594. PubMed ID: 27539577
[TBL] [Abstract][Full Text] [Related]
11. HPV Direct Flow CHIP: a new human papillomavirus genotyping method based on direct PCR from crude-cell extracts.
Herraez-Hernandez E; Alvarez-Perez M; Navarro-Bustos G; Esquivias J; Alonso S; Aneiros-Fernandez J; Lacruz-Pelea C; Sanchez-Aguera M; Santamaria JS; de Antonio JC; Rodriguez-Peralto JL
J Virol Methods; 2013 Oct; 193(1):9-17. PubMed ID: 23680093
[TBL] [Abstract][Full Text] [Related]
12. HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program.
Tabrizi SN; Brotherton JM; Stevens MP; Condon JR; McIntyre P; Smith D; Garland SM;
J Clin Virol; 2014 Jul; 60(3):250-6. PubMed ID: 24854516
[TBL] [Abstract][Full Text] [Related]
13. Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence.
Carozzi F; De Marco L; Gillio-Tos A; Del Mistro A; Girlando S; Baboci L; Trevisan M; Burroni E; Grasso S; Giorgi Rossi P; Ronco G;
J Clin Virol; 2014 Jul; 60(3):257-63. PubMed ID: 24815381
[TBL] [Abstract][Full Text] [Related]
14. A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18-26 years.
Giambi C; Donati S; Carozzi F; Salmaso S; Declich S; Atti ML; Ronco G; Alibrandi MP; Brezzi S; Collina N; Franchi D; Lattanzi A; Minna MC; Nannini R; Barretta E; Burroni E; Gillio-Tos A; Macallini V; Pierotti P; Bella A
BMC Infect Dis; 2013 Feb; 13():74. PubMed ID: 23390953
[TBL] [Abstract][Full Text] [Related]
15. Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes.
Lindemann ML; Dominguez MJ; de Antonio JC; Sandri MT; Tricca A; Sideri M; Khiri H; Ravet S; Boyle S; Aldrich C; Halfon P
J Mol Diagn; 2012 Jan; 14(1):65-70. PubMed ID: 22079749
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders.
Lam JUH; Rebolj M; Ejegod DM; Pedersen H; Rygaard C; Lynge E; Harder E; Thomsen LT; Kjaer SK; Bonde J
J Clin Microbiol; 2017 Oct; 55(10):2913-2923. PubMed ID: 28724554
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus types distribution in organised cervical cancer screening in France.
Heard I; Tondeur L; Arowas L; Falguières M; Demazoin MC; Favre M
PLoS One; 2013; 8(11):e79372. PubMed ID: 24244490
[TBL] [Abstract][Full Text] [Related]
18. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark.
Kjaer SK; Breugelmans G; Munk C; Junge J; Watson M; Iftner T
Int J Cancer; 2008 Oct; 123(8):1864-70. PubMed ID: 18661520
[TBL] [Abstract][Full Text] [Related]
19. Clinical and analytical performance of the CLART HPV 4S assay with SurePath screening samples from the Danish cervical cancer screening program using the VALGENT framework.
Ejegod DM; Pedersen H; Quint W; Xu L; Arbyn M; Bonde JH
J Virol Methods; 2021 Jun; 292():114118. PubMed ID: 33766660
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.
Stevens MP; Garland SM; Rudland E; Tan J; Quinn MA; Tabrizi SN
J Clin Microbiol; 2007 Jul; 45(7):2130-7. PubMed ID: 17494721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
